Click for best price
Hemoglobinopathy Testing Services Market Size, Share 2023
Hemoglobinopathy includes a range of disorders, which occur due to altered structure of hemoglobin. Hemoglobin is present in the red blood cells that transports oxygen from the lung to the body.
This report aims to provide a comprehensive presentation of the global market for Hemoglobinopathy Testing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemoglobinopathy Testing Services. This report contains market size and forecasts of Hemoglobinopathy Testing Services in global, including the following market information:
Global Hemoglobinopathy Testing Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hemoglobinopathy Testing Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hydroxyurea Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hemoglobinopathy Testing Services include Novartis, AstraZeneca, Bluebird Bio, Bristol-Myers Squibb, Emmaus Medical, Acceleron Pharma, HemaQuest Pharmaceuticals, Eli Lilly and Company and Celgene Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hemoglobinopathy Testing Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemoglobinopathy Testing Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hemoglobinopathy Testing Services Market Segment Percentages, by Type, 2022 (%)
Hydroxyurea
Glutamine
Zynteglo
Luspatercept
Others
Global Hemoglobinopathy Testing Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hemoglobinopathy Testing Services Market Segment Percentages, by Application, 2022 (%)
Sickle Cell Diseases
Thalassemia
Other
Global Hemoglobinopathy Testing Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hemoglobinopathy Testing Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemoglobinopathy Testing Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hemoglobinopathy Testing Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
AstraZeneca
Bluebird Bio
Bristol-Myers Squibb
Emmaus Medical
Acceleron Pharma
HemaQuest Pharmaceuticals
Eli Lilly and Company
Celgene Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hemoglobinopathy Testing Services, market overview.
Chapter 2: Global Hemoglobinopathy Testing Services market size in revenue.
Chapter 3: Detailed analysis of Hemoglobinopathy Testing Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemoglobinopathy Testing Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hemoglobinopathy Testing Services Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hemoglobinopathy Testing Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemoglobinopathy Testing Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemoglobinopathy Testing Services Overall Market Size
2.1 Global Hemoglobinopathy Testing Services Market Size: 2022 VS 2029
2.2 Global Hemoglobinopathy Testing Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hemoglobinopathy Testing Services Players in Global Market
3.2 Top Global Hemoglobinopathy Testing Services Companies Ranked by Revenue
3.3 Global Hemoglobinopathy Testing Services Revenue by Companies
3.4 Top 3 and Top 5 Hemoglobinopathy Testing Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hemoglobinopathy Testing Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemoglobinopathy Testing Services Players in Global Market
3.6.1 List of Global Tier 1 Hemoglobinopathy Testing Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Hemoglobinopathy Testing Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hemoglobinopathy Testing Services Market Size Markets, 2022 & 2029
4.1.2 Hydroxyurea
4.1.3 Glutamine
4.1.4 Zynteglo
4.1.5 Luspatercept
4.1.6 Others
4.2 By Type - Global Hemoglobinopathy Testing Services Revenue & Forecasts
4.2.1 By Type - Global Hemoglobinopathy Testing Services Revenue, 2018-2023
4.2.2 By Type - Global Hemoglobinopathy Testing Services Revenue, 2024-2029
4.2.3 By Type - Global Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hemoglobinopathy Testing Services Market Size, 2022 & 2029
5.1.2 Sickle Cell Diseases
5.1.3 Thalassemia
5.1.4 Other
5.2 By Application - Global Hemoglobinopathy Testing Services Revenue & Forecasts
5.2.1 By Application - Global Hemoglobinopathy Testing Services Revenue, 2018-2023
5.2.2 By Application - Global Hemoglobinopathy Testing Services Revenue, 2024-2029
5.2.3 By Application - Global Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hemoglobinopathy Testing Services Market Size, 2022 & 2029
6.2 By Region - Global Hemoglobinopathy Testing Services Revenue & Forecasts
6.2.1 By Region - Global Hemoglobinopathy Testing Services Revenue, 2018-2023
6.2.2 By Region - Global Hemoglobinopathy Testing Services Revenue, 2024-2029
6.2.3 By Region - Global Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hemoglobinopathy Testing Services Revenue, 2018-2029
6.3.2 US Hemoglobinopathy Testing Services Market Size, 2018-2029
6.3.3 Canada Hemoglobinopathy Testing Services Market Size, 2018-2029
6.3.4 Mexico Hemoglobinopathy Testing Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hemoglobinopathy Testing Services Revenue, 2018-2029
6.4.2 Germany Hemoglobinopathy Testing Services Market Size, 2018-2029
6.4.3 France Hemoglobinopathy Testing Services Market Size, 2018-2029
6.4.4 U.K. Hemoglobinopathy Testing Services Market Size, 2018-2029
6.4.5 Italy Hemoglobinopathy Testing Services Market Size, 2018-2029
6.4.6 Russia Hemoglobinopathy Testing Services Market Size, 2018-2029
6.4.7 Nordic Countries Hemoglobinopathy Testing Services Market Size, 2018-2029
6.4.8 Benelux Hemoglobinopathy Testing Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hemoglobinopathy Testing Services Revenue, 2018-2029
6.5.2 China Hemoglobinopathy Testing Services Market Size, 2018-2029
6.5.3 Japan Hemoglobinopathy Testing Services Market Size, 2018-2029
6.5.4 South Korea Hemoglobinopathy Testing Services Market Size, 2018-2029
6.5.5 Southeast Asia Hemoglobinopathy Testing Services Market Size, 2018-2029
6.5.6 India Hemoglobinopathy Testing Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hemoglobinopathy Testing Services Revenue, 2018-2029
6.6.2 Brazil Hemoglobinopathy Testing Services Market Size, 2018-2029
6.6.3 Argentina Hemoglobinopathy Testing Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hemoglobinopathy Testing Services Revenue, 2018-2029
6.7.2 Turkey Hemoglobinopathy Testing Services Market Size, 2018-2029
6.7.3 Israel Hemoglobinopathy Testing Services Market Size, 2018-2029
6.7.4 Saudi Arabia Hemoglobinopathy Testing Services Market Size, 2018-2029
6.7.5 UAE Hemoglobinopathy Testing Services Market Size, 2018-2029
7 Hemoglobinopathy Testing Services Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Hemoglobinopathy Testing Services Major Product Offerings
7.1.4 Novartis Hemoglobinopathy Testing Services Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Hemoglobinopathy Testing Services Major Product Offerings
7.2.4 AstraZeneca Hemoglobinopathy Testing Services Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bluebird Bio
7.3.1 Bluebird Bio Company Summary
7.3.2 Bluebird Bio Business Overview
7.3.3 Bluebird Bio Hemoglobinopathy Testing Services Major Product Offerings
7.3.4 Bluebird Bio Hemoglobinopathy Testing Services Revenue in Global Market (2018-2023)
7.3.5 Bluebird Bio Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Hemoglobinopathy Testing Services Major Product Offerings
7.4.4 Bristol-Myers Squibb Hemoglobinopathy Testing Services Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Emmaus Medical
7.5.1 Emmaus Medical Company Summary
7.5.2 Emmaus Medical Business Overview
7.5.3 Emmaus Medical Hemoglobinopathy Testing Services Major Product Offerings
7.5.4 Emmaus Medical Hemoglobinopathy Testing Services Revenue in Global Market (2018-2023)
7.5.5 Emmaus Medical Key News & Latest Developments
7.6 Acceleron Pharma
7.6.1 Acceleron Pharma Company Summary
7.6.2 Acceleron Pharma Business Overview
7.6.3 Acceleron Pharma Hemoglobinopathy Testing Services Major Product Offerings
7.6.4 Acceleron Pharma Hemoglobinopathy Testing Services Revenue in Global Market (2018-2023)
7.6.5 Acceleron Pharma Key News & Latest Developments
7.7 HemaQuest Pharmaceuticals
7.7.1 HemaQuest Pharmaceuticals Company Summary
7.7.2 HemaQuest Pharmaceuticals Business Overview
7.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Major Product Offerings
7.7.4 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Revenue in Global Market (2018-2023)
7.7.5 HemaQuest Pharmaceuticals Key News & Latest Developments
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Company Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Hemoglobinopathy Testing Services Major Product Offerings
7.8.4 Eli Lilly and Company Hemoglobinopathy Testing Services Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly and Company Key News & Latest Developments
7.9 Celgene Corporation
7.9.1 Celgene Corporation Company Summary
7.9.2 Celgene Corporation Business Overview
7.9.3 Celgene Corporation Hemoglobinopathy Testing Services Major Product Offerings
7.9.4 Celgene Corporation Hemoglobinopathy Testing Services Revenue in Global Market (2018-2023)
7.9.5 Celgene Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hemoglobinopathy Testing Services Market Opportunities & Trends in Global Market
Table 2. Hemoglobinopathy Testing Services Market Drivers in Global Market
Table 3. Hemoglobinopathy Testing Services Market Restraints in Global Market
Table 4. Key Players of Hemoglobinopathy Testing Services in Global Market
Table 5. Top Hemoglobinopathy Testing Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hemoglobinopathy Testing Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hemoglobinopathy Testing Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hemoglobinopathy Testing Services Product Type
Table 9. List of Global Tier 1 Hemoglobinopathy Testing Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemoglobinopathy Testing Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Hemoglobinopathy Testing Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hemoglobinopathy Testing Services Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Hemoglobinopathy Testing Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hemoglobinopathy Testing Services Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Hemoglobinopathy Testing Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hemoglobinopathy Testing Services Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Hemoglobinopathy Testing Services Product Offerings
Table 32. Novartis Hemoglobinopathy Testing Services Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Hemoglobinopathy Testing Services Product Offerings
Table 36. AstraZeneca Hemoglobinopathy Testing Services Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Bluebird Bio Company Summary
Table 39. Bluebird Bio Hemoglobinopathy Testing Services Product Offerings
Table 40. Bluebird Bio Hemoglobinopathy Testing Services Revenue (US$, Mn) & (2018-2023)
Table 41. Bluebird Bio Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Hemoglobinopathy Testing Services Product Offerings
Table 44. Bristol-Myers Squibb Hemoglobinopathy Testing Services Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Emmaus Medical Company Summary
Table 47. Emmaus Medical Hemoglobinopathy Testing Services Product Offerings
Table 48. Emmaus Medical Hemoglobinopathy Testing Services Revenue (US$, Mn) & (2018-2023)
Table 49. Emmaus Medical Key News & Latest Developments
Table 50. Acceleron Pharma Company Summary
Table 51. Acceleron Pharma Hemoglobinopathy Testing Services Product Offerings
Table 52. Acceleron Pharma Hemoglobinopathy Testing Services Revenue (US$, Mn) & (2018-2023)
Table 53. Acceleron Pharma Key News & Latest Developments
Table 54. HemaQuest Pharmaceuticals Company Summary
Table 55. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Product Offerings
Table 56. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Revenue (US$, Mn) & (2018-2023)
Table 57. HemaQuest Pharmaceuticals Key News & Latest Developments
Table 58. Eli Lilly and Company Company Summary
Table 59. Eli Lilly and Company Hemoglobinopathy Testing Services Product Offerings
Table 60. Eli Lilly and Company Hemoglobinopathy Testing Services Revenue (US$, Mn) & (2018-2023)
Table 61. Eli Lilly and Company Key News & Latest Developments
Table 62. Celgene Corporation Company Summary
Table 63. Celgene Corporation Hemoglobinopathy Testing Services Product Offerings
Table 64. Celgene Corporation Hemoglobinopathy Testing Services Revenue (US$, Mn) & (2018-2023)
Table 65. Celgene Corporation Key News & Latest Developments
List of Figures
Figure 1. Hemoglobinopathy Testing Services Segment by Type in 2022
Figure 2. Hemoglobinopathy Testing Services Segment by Application in 2022
Figure 3. Global Hemoglobinopathy Testing Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hemoglobinopathy Testing Services Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hemoglobinopathy Testing Services Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemoglobinopathy Testing Services Revenue in 2022
Figure 8. By Type - Global Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 9. By Application - Global Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 10. By Type - Global Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 12. By Application - Global Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 14. By Region - Global Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 15. By Country - North America Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 16. US Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 20. Germany Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 21. France Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 28. China Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 32. India Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 34. Brazil Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Hemoglobinopathy Testing Services Revenue Market Share, 2018-2029
Figure 37. Turkey Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Hemoglobinopathy Testing Services Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Hemoglobinopathy Testing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Hemoglobinopathy Testing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bluebird Bio Hemoglobinopathy Testing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Hemoglobinopathy Testing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Emmaus Medical Hemoglobinopathy Testing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Acceleron Pharma Hemoglobinopathy Testing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eli Lilly and Company Hemoglobinopathy Testing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Celgene Corporation Hemoglobinopathy Testing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
